66
Participants
Start Date
February 9, 2016
Primary Completion Date
October 6, 2020
Study Completion Date
October 6, 2020
Cobomarsen
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medicine, New York
Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx
Thomas Jefferson University Hospital, Philadelphia
Inova Melanoma and Skin Cancer Center / Inova Schar Cancer Institute, Fairfax
University of Miami Sylvester Comprehensive Cancer Center, Miami
The Ohio State University Comprehensive Cancer Center, Columbus
Northwestern University; Department of Dermatology, Chicago
University of Nebraska Medical Center, Omaha
The University of Texas MD Anderson Cancer Center, Houston
University of Colorado, Anschutz Medical Campus, Aurora
Huntsman Cancer Institute, Salt Lake City
UCLA Department of Medicine, Los Angeles
City of Hope, Duarte
UCSD Moores Cancer Center, La Jolla
Chao Family Comprehensive Cancer Center at University of California, Irvine, Orange
Stanford University Hospital and Clinics, Stanford
Smilow Cancer Hospital at Yale-New Haven, New Haven
Beth Israel Deaconess Medical Center, Boston
miRagen Therapeutics, Inc.
INDUSTRY